Complex migration of MSD instances into SFDC org

January 27, 2023
 by 
Michael Wirth

The customer is a drug discovery and development company headquartered in Germany, operating globally, with about 4,200 employees working across a number of therapeutic areas. Some extraordinary challenges in this migration project included a lack of direct access to source and target systems, and a complex and very comprehensive mapping within a very tight time frame.

Read here how the customer was enabled to overcome these challenges, and what was the result.